Zobrazeno 1 - 10
of 416
pro vyhledávání: '"Ji‐Bin Liu"'
Autor:
Sha Li, Pei Xue, Xun Diao, Qi-Yu Fan, Kun Ye, Xiao-Mei Tang, Jia Liu, Zhong-Yan Huang, Qing-Hai Tang, Cheng-You Jia, Rui Xin, Zhong-Wei Lv, Ji-Bin Liu, Yu-Shui Ma, Da Fu
Publikováno v:
Journal of Advanced Research, Vol 54, Iss , Pp 133-146 (2023)
Background: Aberrations in MYC underlie a large proportion of liver hepatocellular carcinoma (LIHC) cases; however, MYC is difficult to target because of its undruggable structure. We aimed to uncover MYC-associated molecular targets to provide new s
Externí odkaz:
https://doaj.org/article/5b1dc4ef0d4d432f81b40b8b4b5c5ebe
Publikováno v:
Advanced Ultrasound in Diagnosis and Therapy, Vol 8, Iss 3, Pp 93-93 (2024)
Externí odkaz:
https://doaj.org/article/0c5f8d50158b4fca87eafb19f28d16b1
Autor:
Meng Zhang, Lin Jiang, Xin-Yun Liu, Fu-Xing Liu, Hui Zhang, Yan-Juan Zhang, Xiao-Mei Tang, Yu-Shui Ma, Hui-Yi Wu, Xun Diao, Chun Yang, Ji-Bin Liu, Da Fu, Jie Zhang, Hong Yu
Publikováno v:
Heliyon, Vol 10, Iss 1, Pp e24287- (2024)
Pancreatic adenocarcinoma (PAAD) remains challenging to diagnose and treat clinically due to its difficult early diagnosis, low surgical resection rate, and high risk of postoperative recurrence and metastasis. SMAD4 is a classical mutated gene in pa
Externí odkaz:
https://doaj.org/article/e81d98cbd2484fa6abd4712c96ba4ad9
Autor:
Xue-Chen Yu, Ji-Bin Liu, Qing-Hai Tang, Xun Diao, Qi-Yu Fan, Zhong-Yan Huang, Xiao-Mei Tang, Sha Li, Yong-Feng Cao, Yu-Shui Ma, Da Fu
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 2785-2795 (2022)
Background Improvements in screening and imaging technologies and treatment of liver disease have influenced the trend in diagnosis for stage I liver cancer. In this article, recent trends in age, incidence, tumour size, and survival of different sta
Externí odkaz:
https://doaj.org/article/c2338364dbd14e679fdfd1088e96a84b
Publikováno v:
Journal of Advanced Research, Vol 40, Iss , Pp 135-152 (2022)
Background: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is derived from the bacterial innate immune system and engineered as a robust gene-editing tool. Due to the higher specificity and efficiency of CRISPR/Cas9, it has been w
Externí odkaz:
https://doaj.org/article/fd2a3e0845474a2696663e896809ff24
Autor:
Wen Li, Ji-Bin Liu, Li-Kun Hou, Fei Yu, Jie Zhang, Wei Wu, Xiao-Mei Tang, Feng Sun, Hai-Min Lu, Jing Deng, Jie Bai, Juan Li, Chun-Yan Wu, Qin-Lu Lin, Zhong-Wei Lv, Gao-Ren Wang, Geng-Xi Jiang, Yu-Shui Ma, Da Fu
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-15 (2022)
Abstract Primary lung cancer is one of the most common malignant tumors in China. Approximately 60% of lung cancer patients have distant metastasis at the initial diagnosis, so it is necessary to find new tumor markers for early diagnosis and individ
Externí odkaz:
https://doaj.org/article/3a357a95ed7247f89b0e45c539a2114a
Autor:
Yu-Shui Ma, Kai-Jian Chu, Chang-Chun Ling, Ting-Miao Wu, Xu-Chao Zhu, Ji-Bin Liu, Fei Yu, Zhi-Zhen Li, Jing-Han Wang, Qing-Xiang Gao, Bin Yi, Hui-Min Wang, Li-Peng Gu, Liu Li, Lin-Lin Tian, Yi Shi, Xiao-Qing Jiang, Da Fu, Xiong-Wen Zhang
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 30, Iss , Pp 324- (2022)
Externí odkaz:
https://doaj.org/article/7ad2da247b944c84b179fbeae5fd10cd
Autor:
Yi Shi, Ji-Bin Liu, Jing Deng, Da-Zhi Zou, Jian-Jun Wu, Ya-Hong Cao, Jie Yin, Yu-Shui Ma, Fu Da, Wen Li
Publikováno v:
Hereditas, Vol 158, Iss 1, Pp 1-14 (2021)
Abstract Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide due to its high degree of malignancy, high incidence, and low survival rate. However, the underlying mechanisms of hepatocarcinogenesis remain uncl
Externí odkaz:
https://doaj.org/article/5f9ac49ea2604ea49578bba60363cc81
Autor:
Yu-Shui Ma, Li-Kun Hou, Shi-Hua Yao, Ji-Bin Liu, Xue-Chen Yu, Yi Shi, Xiao-Li Yang, Wei Wu, Chun-Yan Wu, Geng-Xi Jiang, Da Fu
Publikováno v:
Molecular Therapy: Oncolytics, Vol 22, Iss , Pp 326-335 (2021)
Drug resistance is a key factor in the treatment failure of clinical non-small cell lung cancer (NSCLC) patients after adjuvant chemotherapy. Here, our results provide the first evidence that eukaryotic translation initiation factor 2b subunit delta
Externí odkaz:
https://doaj.org/article/452076915f8e4b2c81a53214cb86367c
Autor:
Yu-Shui Ma, Xiao-Li Yang, Yu-Shan Liu, Hua Ding, Jian-Jun Wu, Yi Shi, Cheng-You Jia, Gai-Xia Lu, Dan-Dan Zhang, Hui-Min Wang, Pei-Yao Wang, Fei Yu, Zhong-Wei Lv, Gao-Ren Wang, Ji-Bin Liu, Da Fu
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-14 (2021)
Abstract Background Cancer stem cells (CSCs) are key regulators in the processes of tumor initiation, progression, and recurrence. The mechanism that maintains their stemness remains enigmatic, although the role of several long noncoding RNAs (lncRNA
Externí odkaz:
https://doaj.org/article/297be5d3e6ba43fe9a25448b08c820e1